XNCR Xencor, Inc. Net earnings per share growth this year

XNCR (Xencor, Inc.) - company brandmark

Xencor, Inc. (XNCR) protects its position in immuno-oncology through its unique XmAb platform, which is leased by the largest pharmaceutical companies. The annual growth rate of earnings per share visualizes this trend, while the value of -96.20 reflects the metric's balance. However, fierce competition for treatment standards with industry behemoths and a reliance on licensing royalties create certain risks for the development of its own drug portfolio.

Xencor (XNCR): Net earnings per share growth this year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Xencor Inc. (XNCR)

- current quotes and average value forecast:
Summary company analysis:XNCR (Xencor, Inc.)
Brand item of Xencor Corp

This indicator measures the annual dynamics of net profit per share, reflecting the efficiency of business capitalization through the percentage deviation of the current EPS from the previous year's value. By analyzing the annual EPS variable, the investor assesses the extent to which the Xencor, Inc. (XNCR) strategy of outsourcing production and testing to external contractors optimizes costs and contributes to the growth of real shareholder returns.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|CMPX (compasstherapeutics.com) - Earnings per share growth this year|Replimune Inc. (REPL) - Earnings per share growth in current year|Earnings per share growth rate in current year Lyell Immunopharma Inc (LYEL)|Net earnings per share growth this year IPHA|PYXS - Net earnings per share change in current year|Net earnings per share growth this year CGEN (Compugen Ltd.)|Net earnings per one share growth for the current year IOBT|Earnings growth in current year STRO (Sutro Biopharma)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma|ALX Oncology (ALXO) - Earnings per share growth in current year|cuebiopharma.com (CUE) - Earnings growth in current year|PDSB (PDS Biotechnology Corp) - Earnings growth in current year|Earnings growth in current year sonnetbio.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year